FIELD: biopharmacology, medicine.
SUBSTANCE: the suggested biotransplant contains an active component: the culture of genetically unmodified neuronal stem cells (NSC) obtained out of anterior cerebral tissue of human embryos of the 1st trimester of pregnancy or periventricular cerebral area of 15-20 wk gestation and selectively multiplied under cultivating conditions up to the quantity of 10 (7) - 10 (9) pluripotent undifferentiated cells in composition of neurospheres, at the content of NSC being 50-500 mln., and 2 ml physiological solution. The method for treating ischemic insult deals with introduction of 50-500 mln. NSC in 2 ml physiological solution. The suggested biotransplant and method for treating ischemic insult enable to quickly restore and improve cerebral functions.
EFFECT: shortened terms of therapy.
5 cl, 2 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
BIOTRANSPLANT AND METHOD FOR TREATING THE CASES OF PARKINSONISM | 2004 |
|
RU2259836C1 |
METHOD FOR TREATING STROKE CASES | 2004 |
|
RU2283121C2 |
METHOD FOR TREATMENT OF ORGANIC DAMAGE IN CENTRAL NERVOUS SYSTEM BY ENDOLUMBAL TRANSPLANTATION OF HUMAN FETAL CELLS | 2002 |
|
RU2234930C2 |
TRUNCAL NERVE CELLS, CELLS CULTURE AND BIOTRANSPLANT FOR ALLOTRANSPLANTING AND METHOD FOR PREPARING THE BIOTRANSPLANT | 2001 |
|
RU2191388C1 |
METHOD FOR TREATING CRANIOCEREBRAL TRAUMA | 2002 |
|
RU2252023C2 |
METHOD OF TREATING POSTTRAUMATIC ENCEPHALOPATHY | 2009 |
|
RU2413523C2 |
METHOD FOR TREATING ACUTE CEREBRAL STROKE CASES | 2005 |
|
RU2268064C1 |
METHOD OF ACUTE CEREBRAL CIRCULATION DISORDER COURSE FORECAST | 2007 |
|
RU2327994C1 |
METHOD OF TREATMENT OF SEPTIC ENCEPHALOPATHY USING CEREBROLYSIN | 2022 |
|
RU2798717C1 |
BIOMEDICAL CELL PRODUCT FOR TREATING NERVOUS DISEASES AND MENTAL DISORDERS, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2018 |
|
RU2720002C1 |
Authors
Dates
2005-08-20—Published
2004-03-19—Filed